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http://dxBackground: Adhesions may increase the incidence of lethal complications of cardiac reoperations, which
account for up to 20% of all open-heart surgeries. Herein, we describe the use of a polyvinyl alcohol membrane
(PVAM) as a pericardial alternative and describe its performance during reoperation in a relevant animal model.
Methods: The PVAM samples were reticulated by electron beam radiation and manipulated into a tube shape.
After thoracotomy, the pericardium of Wistar rats was opened to expose the heart. Rats were treated by pushing
the heart back into the thoracic cavity (Sham group), sprinkling the epicardiumwith talcum powder (Talc group),
encircling the heart with PVAM (PVAM group), or sprinkling the epicardiumwith talcum powder before placing
the PVAM to encircle the heart (PVAMþ Talc group). Animals were recovered for 8 weeks and then euthanized.
Macroscopic findings (ie, extent and severity of adhesions) were classified according to a 4-grade adhesion scale.
The PVAM was tested for direct and indirect cytotoxicity with Vero cells. The water absorption capability and
in vivo calcification after 8 weeks of subcutaneous implantation of the membrane were examined. Data were
analyzed by analysis of variance and Bonferroni post hoc tests.
Results: The PVAM group had lower adhesion scores than the Talc and Sham groups, as well as reduced
epicardium thickness and inflammatory cell results, compared with the Talc and PVAM þ Talc groups.
The PVAM exhibited no direct or indirect cytotoxicity, good water absorption capability (42.4%  0.9%),
and negligible calcification after 8 weeks (4.42 3 103  2.56 3 103 percentage of the total mass).
Conclusions: The PVAM shows promising properties for its potential use as a novel pericardial substitute.
(J Thorac Cardiovasc Surg 2014;147:1405-10)Pericardial and mediastinal adhesions increase the morta-
lity and morbidity rates after cardiac reoperations.1,2
Many individuals with congenital heart defects will
require multiple repeat sternotomies. Numerous strategies
have been described for reducing postoperative adhesions,
such as sprinkling solutions into the pericardial sac or
using expanded polytetrafluoroethylene (ePTFE) or
bioabsorbable gelatin sheets.3-5 However, there is no
accepted approach for reducing adhesion formation after
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Sassembled from 10% polyvinyl alcohol (PVA). We
examined the use of this PVA hydrogel membrane
(PVAM) as a pericardial substitute in an animal model of
adhesion formation, focusing on its cytotoxic effects and
inflammatory potential.
METHODS
Assembling the PVAM
The PVAM was made as described previously.7 Briefly, the membrane
was assembled from an aqueous solution of 10% PVA (Sigma Aldrich,
S~ao Paulo, Brazil), which was kept at room temperature for 7 days until
dry. The dried membrane was 2-mm thick, and it was manipulated into a
tube-like shape (1.5-cm height and 0.5-cm internal diameter).
The PVAMwas subjected to a cross-linking step to stabilize the polymer
and prevent its dissolution in contacted fluids. This step has prevented
PVAM dissolution for at least 24 weeks after implantation in bone tissue.7
Electron beam irradiation, which can simultaneously accomplish the
reticulation and sterilization of the membranes, was performed for the
cross-linking step. Before irradiation, the material was acetylated by
immersion in a solution of 40% formaldehyde, 50% sulfur acid, and
300 g of anhydrous sodium sulfate at 60C for 24 hours. The PVAMs
were washed to remove any residual chemical and stored in distilled water.
The membranes were cross-linked by electron beam irradiation with 25
kGy using a Radiation Dynamics electron beam accelerator (Instituto de
Pesquisas Energeticas e Nucleares, S~ao Paulo). After this process, the
PVAMs were considered to be sterilized and ready for use.diovascular Surgery c Volume 147, Number 4 1405
FIGURE 1. Inflammatory cell count (A) and epicardial thickness (B) in
all 4 groups after 8 weeks of observation. Bar height indicates mean,
with error bar showing standard error of mean. P values by analysis of vari-
ance with post hoc Bonferroni for multiple comparisons. PVAM, Polyvinyl
alcohol membrane.
Abbreviations and Acronyms
CMC ¼ carboxymethylcellulose
ePTFE ¼ expanded polytetrafluoroethylene
PVAM ¼ polyvinyl alcohol membrane
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Ethical approval was obtained from the local institutional review board.
All animal handling and experiments were performed in accordance with
the standards of the Brazilian Council for Animal Experimentation and
the 1996 Guide for the Care and Use of Laboratory Animals, published
by the National Institutes of Health. Animals were maintained under
specific pathogen-free conditions, a 12-hour/12-hour light/dark cycle,
and a room temperature of 21C.
Four-week-old male Wistar rats (average weight, 300 g) were
anesthetized with 2% isoflurane. A left thoracotomy was performed, the
pericardium was opened, and the heart was exposed. Animals were
randomized into 4 groups (10 animals per group). In the Sham group, the
heart was pushed back to the thoracic cavity, and the incision was closed.
In the Talc group, talcum powder (10 mg) was sprinkled over the
epicardium. In the PVAM group, a PVAM tube was inserted into the
thoracic cavity and used to encompass the heart from the surrounding
tissue, except for where the major vessels exited/entered the heart. Finally,
in the PVAMþ Talc group, talcum powder (10 mg) was sprinkled over the
epicardium, and then a PVAM tubewas inserted into the thoracic cavity and
used to encompass the heart completely. No sutures were needed to hold the
PVAM tube in place, because of its flexibility and the limited nature of the
thoracic space.
All animals were recovered from anesthesia for 8 weeks, during which
time they were provided standard chow and water ad libitum. Eight weeks
after the surgical protocol, the animals were euthanizedwith an intravenous
dose of pentobarbital, the thoracic cavity was opened, and any adhesions
were lysed. Two observers (P.P.M.O. and V.P.B.), blinded to each other,
scored the adhesions from 0 to 3, according to an adaptation of the score
described by Kajihara and colleagues8: 0, absence of adhesions; 1, weak
adhesions that are easily lysed; 2, moderate adhesions that are lysed with
dissection; and 3, severe adhesions that require sectioning by scissors for
removal. In all animals, the PVAM tube was inspected for its correct posi-
tion involving the heart.
Histologic Assessment
Cardiac tissue was fixed in 10% paraformaldehyde, embedded in
paraffin, cut into slices, and stained with hematoxylin and eosin. For the
inflammatory cell count and epicardial thickness assessments, a midportion
of the left ventricle (ie, at the papillary muscle level) was used in all ani-
mals. A blinded observer randomly chose 3 optical fields (403 magnifica-
tion) to evaluate the inflammatory cell count and the epicardial thickness.
Physical and Biological Characteristics of the PVAMs
Indirect and direct cytotoxicity assays were performed with an African
greenmonkey epithelial kidney cell line (Vero cells; Instituto Adolfo Luftz,
S~ao Paulo). To assess the indirect cytotoxicity, PVAMs (0.2 g/mL) in the
liquid state without cross-linking were mixed in HAM F-10 media (Sigma
Aldrich) containing 10% fetal bovine serum (Nutricell, Campinas, Brazil)
at 37C. Different concentrations of the membrane solution were added to
cell media containing 3 3 105 cells/mL. After 24 hours, the cell viability
was assessed with the (dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide colorimetric method at 550 nm.9 The negative control was an
extract of 2% polystyrene in a solution of 10% bovine serum albumin
and 10% phenol.
To assess the direct cytotoxicity, Vero cells were seeded and grown over
reticulated and sterilized PVAMs. HAM F-10 media containing 10% fetal1406 The Journal of Thoracic and Cardiovascular Surbovine serum was added, and the cells were grown at 37C for 24 hours.
Cell viability was assessed by the MMT (3-[4,5-dimethylthiazol-2-yl]-
2,5- diphenyltetrazolium bromide; thiazolyl blue) colorimetric method.9
Two controls were used: a positive control, containing 10% phenol in
the media for 24 hours; and a negative control, containing only media.
The hydration capacity of the membranes was evaluated with dry
samples of PVAM immersed in distilled water until a stable membrane
weight was reached. Five measurements were made, and the hydration
capacity was expressed as a percentage. The in vivo calcification index
was determined by implanting a PVAM (1 cm2) subcutaneously (s.c.) ongery c April 2014
FIGURE 2. Representative images of pericardial adhesions (top) and the average adhesion scores (bottom) in each of the 4 groups 8 weeks after treatment
(n ¼ 10 animals in each group). Bar height indicates mean, with error bars showing standard error of mean. P values by analysis of variance with post hoc
Bonferroni for multiple comparisons. PVAM, Polyvinyl alcohol membrane.
de Oliveira et al Evolving Technology/Basic Sciencethe dorsal segment of a Wistar male rat (n ¼ 10). Eight weeks after
implantation, the animals were euthanized, and the membrane calcium
content was assessed with x-ray fluorescence analysis. The membranes
were dried at room temperature and inserted into an x-ray fluorescence
spectrometer (EDX 700; Shimadzu, Columbia, Md). The AXIL software
package (IAEA Laboratories, Seibersdorf, Austria) was used to determine
the calcium content, which was expressed as a percentage of the total mass
of the material analyzed.
Statistical Analysis
All values are reported as means with SDs. Categorical variables are
expressed as frequencies. An analysis of variance with the post hoc
Bonferroni test was used for multiple comparisons. Differences with
P< .05 were considered statistically significant. The GraphPad Prism,
version 6, software package was used for all analyses (GraphPad Software,
La Jolla, Calif).
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The average membrane hydration capacity was 42.4%
0.89%. The average calcium content of PVAMs after
4 weeks of s.c. implantation was 4.42 3 103 
2.56 3 103 percentage of the total mass. The number of
inflammatory cells was similar between the Sham and
PVAM groups and was generally less than the number
observed in the Talc and PVAM þ Talc groups (Figure 1,
A). The epicardial thickness was similar between the
Sham, Talc, and PVAM groups and was thinner than the
epicardium in the PVAM þ Talc group (P < .001)
(Figure 1, B). No adhesion was observed in any animal inThe Journal of Thoracic and Carthe PVAM group, which was a significant result compared
with the other groups (Figure 2). The PVAMs did not
demonstrate direct or indirect cytotoxic effects (Figure 3).
DISCUSSION
Adhesions offer a major challenge in cardiac surgery
reoperations, especially for planned reoperations, such as
in patients with congenital heart defects.10,11 Various
materials have been developed for diminishing pericardial
adhesions, such as resorbable collagen membranes,
biodegradable collagen-elastin membranes, propylene
oxide–treated bovine pericardium, and bioabsorbable
gelatin sheets.5,7,12-14 Herein, we evaluated a novel PVA
membrane as a pericardial substitute. In vitro, the PVAM
showed a high hydration capacity and no cytotoxic effect
after direct or indirect contact with cultured cells. After 8
weeks of s.c. implantation in rats as a pericardial
substitute, the PVAMs showed a low calcification index
and a low inflammatory effect. In these rats, few
adhesions were observed between the epicardium and the
surrounding structures of the thoracic cavity. Although
PVA-based materials have been used in other biomedical
applications,7 to the best of our knowledge, this report
represents the first time that a PVA membrane has been
used as a pericardial substitute.
Our findings are consistent regarding the method used,
with adhesion scores and microscopic findings obtaineddiovascular Surgery c Volume 147, Number 4 1407
FIGURE 3. Results of direct and indirect cytotoxicity tests after 24 hours of cell growth in the 4 groups. Confluence of cells in the negative control (A) and
the positive control (B). Confluence of cells under conditions of direct toxicity (C) and indirect toxicity (D). Bar height indicates mean, with error bars
showing standard error of mean. P values by analysis of variance with post hoc Bonferroni for multiple comparisons.
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Sby a blinded observer. Previous reports have used similar
methods with different membranes or biodegradable
materials.8,14-16 Although we did not compare the PVAM
with any commercially available membrane, we found
promising results compared with Bel and colleagues,17
who reported similar adhesion scores using a sheep model
with an absorbable collagen membrane after 8 weeks of
implantation. In the present study, we observed almost no
adhesions between the PVAM-protected epicardium and
the adjacent thoracic structures after 8 weeks of
implantation.1408 The Journal of Thoracic and Cardiovascular SurA polyvinyl alcohol with carboxymethylcellulose (PVA/
CMC) hydrogel has been used in different tissues.18,19
Slieker and colleagues19 evaluated use of the PVA/CMC
hydrogel as an adhesion barrier in colon anastomoses.
They found that the hydrogel did not interfere with healing
of the anastomotic site and did not prevent adhesion
formation. The neutral effect reported by Slieker and
colleagues19 regarding adhesion formation might be due
to the hydrogel format of the PVA/CMC. In particular, the
hydrogel was completely absorbed after 3 to 4 weeks and
eliminated via urinary excretion. The hydrogel formatgery c April 2014
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the anastomotic site was not ensured.19 In the present study,
at 8 weeks after its implantation, the tube-shaped PVAM
was not absorbed and continued to maintain its position
encompassing the heart. The cross-linking process used
during membrane assembly ensured that a stable membrane
could be maintained for at least 24 weeks after bone tissue
implantation.7
In another study, Slieker and colleagues evaluated use
of the PVA/CMC hydrogel in a rat model of peritonitis,18
finding that the PVA/CMC hydrogel reduced adhesions in
the viscera compared with the control group. This result
may be because of the nature of hydrogel, which might
distribute more homogenously between the peritoneum
and abdominal viscera.18 In a swine model of chronic
ischemia, Lassaletta and colleagues20 showed that
alcohol use had beneficial effects on precluding adhesion
formation between the pericardium and epicardium.
They simulated coronary ischemia with an aneroid
constrictor to induce chronic coronary insufficiency.
The animals were fed a high-cholesterol diet supple-
mented with either vodka or red wine. The experimental
group that received vodka exhibited fewer pericardial
adhesions, less intramyocardial fibrosis, and reduced
C-reactive protein levels, indicating a lower inflamma-
tory response.20,21
In our study, the PVAM group showed a low inflamma-
tory cell density compared with the other groups. Inflamma-
tory cells play important roles in the healing process and
may increase the presence of adhesions.13 We used talcum
powder as an irritant agent for better evaluation of the
PVAM properties. Interestingly, we observed that the
PVAM þ Talc group showed a similar adhesion score to
the control group. This indirect observation may indicate
that the PVAM protected the surrounding tissues from the
talcum powder that was sprinkled over the epicardium.
Virtually, the only adhesions that did occur were observed
inside the PVAM tube, which was created to simulate the
pericardial membrane (Figure 2).
Our study had some limitations. The model may not
simulate all postoperative and thoracic reentry scenarios
after cardiopulmonary bypass. Talcum was used as an
irritant factor in the absence of blood in the pericardium.
This situation does not reflect the true scenario after an
open-heart surgery. As a result, the rate of adhesion
formation in this model may have been decreased compared
with the clinical situation.13 Despite the differences
observed among the groups, the period of 8 weeks is short,
and reoperations within 4 weeks are infrequent. Finally, the
mechanism by which PVAM prevented adhesion formation
is not clear and will require further investigation. Despite
these limitations, it was evident that the PVAM elicited little
inflammatory response and precluded the occurrence of
adhesions.The Journal of Thoracic and CarThe PVAM offers several clinical advantages, in terms of
its transparency, malleability, elasticity, and possibility of
being sewn into the mediastinum. Some of the commer-
cially available membranes are bovine or porcine derived,
which may elicit an inflammatory response or adhesion
formation.10,17 Others, such as those made of ePTFE, are
not transparent and have limited malleability compared
with the PVAM. Our findings offer the possibility of a
new membrane for use as a pericardial substitute before
planned reoperations, especially in newborns and infants
who are more likely to have several surgical interventions
in their pathway for a definitive surgical treatment. This
new membrane may contribute to reduce the occurrence
of adverse events, especially in patients with planned
reintervention because of the nature of their initial
disease.22-25CONCLUSIONS
The use of PVA membranes reduces the occurrence of
adhesions and promotes fewer epicardial reactions, which
may facilitate later reoperation.References
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